-
Posted by
Two Blokes Tue at 5:15 PM -
Filed in
Stock
-
2 views
ACADIA Pharmaceuticals posted better-than-expected Q1 results earlier this month. The company has a rock solid balance sheet and advancing a couple of key drug candidates within its pipeline. An updated analysis around ACADIA Pharmaceuticals follows in the paragraphs below.
